Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
更大的訊號是，AI 正從展示走進預算、規則、安全流程與資本配置。
參考來源: BusinessWire; BioSpace; Precision Medicine Online; CocoLoop, CocoLoop.